by Cherry Salazar | Sep 22, 2025
Moderna, which led the biotechnology sector’s pandemic-driven surge, struggles to keep pace with the market. Moderna, Inc.’s windfall during the pandemic has now become its headwind. Once propelled to record highs by its breakthrough messenger RNA technology, the...
